It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The linkages between intimate partner violence, posttraumatic stress disorder, and insomnia have only recently been the subject of inquiry. Until this study, research about the relationship between insomnia and posttraumatic stress disorder in the lives of intimate partner violence victims has been non-existent. This study begins to address a gap in the literature by analyzing associations between intimate partner violence, clinical level insomnia, posttraumatic stress disorder symptoms, age, race, employment status, and intimate partner violence victims' return to court.
In particular, this exploratory study examines whether clinical level insomnia, posttraumatic stress disorder symptoms, or both are associated with a greater probability that a victim of intimate partner violence will not return to court to pursue a permanent civil order of protection. Data were collected through surveys, interviews, and reviews of court records on 112 women who resided in upstate New York. Study participants initiated actions to obtain orders of protection from the Domestic Violence Intensive Intervention Court, a specialized domestic violence civil court, from 2007 to 2008. The following factors were analyzed to determine their impact on whether a woman returned to court: (a) age, (b) race, (c) employment status, (d) perceived danger, (e) posttraumatic stress disorder symptoms, and (f) clinical level insomnia. This study finds significant relationships between several factors: clinical level insomnia and perceived danger, clinical level insomnia and posttraumatic stress disorder symptoms, race and return to court, and severe danger level and return to court. However, in the final logistic regression models, only race emerged as a predictor of whether a woman returned to court. Specifically, women of color were a third less likely to return court than white women. These results have significant implications for future research and clinical intervention.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer